AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses …
Daily Archives
December 9, 2021
-
OPPO will outline its latest strategy and introduce several exciting technologies at the upcoming OPPO INNO Day 2021, which is set to be held on 14-15 December 2021. Set to …
-
By Eleni Giokos, Anchor & Correspondent, CNN At the end of last week, I wrapped up the last of my work commitments in Johannesburg and prepared to head to the …